CAS: 1313738-90-7
| Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
|---|---|---|---|---|
 | 2-Anthracenesulfonamide, 9,10-dihydro-3,4-dihydroxy-9,10-dioxo-N-[4-(trifluoromethyl)phenyl]- REF: IN-DA000W1PCAS: 1313738-90-7 | 99.34% | Nachfragen | Do 14 Nov 24 |
 | PGMI-004A REF: TM-T16517CAS: 1313738-90-7 | 98% | 131,00 €~2.075,00 € | Do 02 Jan 25 |
![2-Anthracenesulfonamide, 9,10-dihydro-3,4-dihydroxy-9,10-dioxo-N-[4-(trifluoromethyl)phenyl]-](https://static.cymitquimica.com/products/IN/thumb/DA000W1P.jpg)
2-Anthracenesulfonamide, 9,10-dihydro-3,4-dihydroxy-9,10-dioxo-N-[4-(trifluoromethyl)phenyl]-
CAS:1313738-90-7
Formel:
C21H12F3NO6S
Reinheit:
99.34%
Molekulargewicht:
463.3833
Ref: IN-DA000W1P
| 1mg | 525,00 € | ||
| 5mg | Nachfragen | ||
| 10mg | Nachfragen |
Voraussichtliche Lieferung in Vereinigte Staaten, am Donnerstag 14. November 2024
PGMI-004A
CAS:1313738-90-7
PGMI-004A is an effective inhibitor of phosphoglycerate mutase 1 (IC50: 13.1 μM).
Formel:
C21H12F3NO6S
Reinheit:
98%
Farbe und Form:
Solid
Molekulargewicht:
463.38
Ref: TM-T16517
| 5mg | 325,00 € | ||
| 25mg | 916,00 € | ||
| 50mg | 1.301,00 € | ||
| 100mg | 2.075,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Donnerstag 2. Januar 2025
